Header Logo

Connection

Richard De Vuyst to Cystic Fibrosis

Back to Details
This is a "connection" page, showing publications Richard De Vuyst has written about Cystic Fibrosis.
Richard De Vuyst
Connection Strength
1.708
Cystic Fibrosis
  1. Medication utilization and lung function changes after initiation of treatment with elexacaftor/tezacaftor/ivacaftor. Pediatr Pulmonol. 2024 Jul; 59(7):2051-2054.
    View in: PubMed
    Score: 0.889
  2. Elexacaftor/tezacaftor/ivacaftor treatment reduces airway inflammation in cystic fibrosis. Pediatr Pulmonol. 2023 05; 58(5):1592-1594.
    View in: PubMed
    Score: 0.819
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.